R&D Execs Paint Bleak Picture Of Industry Productivity: $1.4 Bil. Per NME

Pharmaceutical R&D execs estimate the cost of drug development to be $1.4 bil. per new molecular entity, Wyeth R&D President Robert Ruffolo, PhD, told an IBC conference in Boston Aug. 12